[1] Bray F,Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424. [2] Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol, 2019, 16(10):589-604. [3] 陈惠春, 涂海斌, 林健玲. 超声弹性成像联合血清学检查预测HCC MVI研究. 中华肝胆外科杂志, 2021, 27(10): 744-747. [4] Lee S, Kim SH, Lee JE, et al. Preoperativegadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol,2017,67(3): 526-534. [5] Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol, 2019, 70(6): 1133-1144. [6] Ma X, Wei J, Gu D, et al. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT. Eur Radiol, 2019, 29(7): 3595-3605. [7] Li M, Yin Z, Hu B, et al. MR elastography-based shear strain mapping for assessment of microvascular invasion in hepatocellular carcinoma. Eur Radiol, 2022, 32(7): 5024-5032. [8] Wang WT, Yang L, Yang ZX, et al. Assessment of microvascular invasion of hepatocellularcarcinoma with diffusion kurtosis imaging. Radiology, 2018, 286(2): 571-580. [9] Qi YP,Zhong JH, Liang ZY, et al. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion. Am J Surg, 2019, 217(4): 739-744. [10] Chen J, Zhou J,Kuang S, et al. Liver imaging reporting and data system category 5 (LI-RADS LR-5): MRI predictors of microvascular invasion and recurrence after hepatectomy for hepatocellular carcinoma. AJR, 2019, 213(4): 821-830. [11] Feng ST, Jia Y, Liao B, et al. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI. Eur Radiol, 2019 , 29(9): 4648-4659. [12] 朱永健,冯冰,王炳智,等. 钆塞酸二钠增强磁共振成像联合磁共振扩散加权成像对肝细胞癌微血管侵犯和预后的预测价值. 中华肿瘤杂志, 2021, 43(3):312-317. [13] 张坤,张天奇,谢双双,等. 基于钆塞酸二钠增强MRI的临床评分模型预测肝细胞癌微血管侵犯的多中心研究. 中华放射学杂志,2022,56(10):1115-1120. [14] Ji GW, Zhu FP, Xu Q, et al.Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a multi-institutional study radiology, 2020, 294(3): 191470. [15] Wang XH, Long LH, Cui Y, et al. MRI-basedradiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma. Br J Cancer, 2020,122(7):978-985. [16] 张煌斌, 鄢业鸿, 万昊, 等. 基于SII、AFP和肿瘤长径的HCC术前MVI的预测研究. 中华肝胆外科杂志, 2021, 27(10): 733-738. [17] 赵晖, 陈骏, 严笑鹏,等. HCC患者MVI的组织学风险分级与预后的关系. 中华肝胆外科杂志, 2019, 25(6): 401-405. [18] 刘红枝, 林海涛, 林昭旺, 等. 机器学习算法在HCCMVI术前预测中的应用价值. 中华消化外科杂志, 2020, 19(2): 156-165. [19] Li Y, Xu X, Weng S, et al. CT image-based texture analysis to predict microvascular invasion in primary hepatocellular carcinoma. J Digit Imaging, 2020, 33(6): 1365-1375. [20] Wang X, Wang W, Ma X, et al. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? Eur Radiol, 2020, 30(10): 5337-5347. [21] Zhang XP, Zhou TF, Wang ZH, et al. Association of preoperative hypercoagulability with poor prognosis in hepatocellular carcinoma patients with microvascular invasion after liver resection: a multicenter study. Ann Surg Oncol, 2019, 26(12): 4117-4125. [22] Lian L, Bo L, Ming Z. Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysis. Acta Radiol, 2020,61(6): 723-731. [23] Jiang H, Wei J, FuF,et al. Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI. Liver Int, 2022, 42(5):1158-1172. [24] Lee S, Kang TW, Song KD,et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg, 2021, 273(3):564-571. |